CRDF·14147L108·US·equity·Healthcare - Biotechnology-13D/G
CRDF (CARDIFF ONCOLOGY INC) is held by 66 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($6.4M), GEODE CAPITAL MANAGEMENT, LLC ($2.6M), FRANKLIN RESOURCES INC ($2M). Net institutional sentiment: Mixed.
See how CRDF's score breaks down across 4 SEC sources
Showing 1-20 of 73
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer